Cargando…

Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction

BACKGROUND: The incidence of premature myocardial infarction (PMI) has gradually increased in recent years. Genetics plays a central role in the development of PMI. Familial hypercholesterolemia (FH) is one of the most common genetic disorders of cholesterol metabolism leading to PMI. OBJECTIVE: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chongyou, Cui, Yuxia, Song, Junxian, Li, Sufang, Zhang, Feng, Wu, Manyan, Li, Long, Hu, Dan, Chen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458678/ https://www.ncbi.nlm.nih.gov/pubmed/30971288 http://dx.doi.org/10.1186/s12944-019-1042-3

Ejemplares similares

Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction
por: Cui, Yuxia, et al.
Publicado: (2019)

Digenic mutations on SCAP and AGXT2 predispose to premature myocardial infarction
por: Gao, Yuanfeng, et al.
Publicado: (2017)

Prothrombin G20210A (rs1799963) polymorphism increases myocardial infarction risk in an age-related manner: A systematic review and meta-analysis
por: Li, Changlong, et al.
Publicado: (2017)

Familial hypercholesterolemia in very young myocardial infarction
por: Li, Sha, et al.
Publicado: (2018)

Incidence and predictors of left ventricular function change following ST-segment elevation myocardial infarction
por: Liu, Chuanfen, et al.
Publicado: (2023)

Circulating microRNAs as potential biomarkers for coronary plaque rupture
por: Li, Sufang, et al.
Publicado: (2017)

Genetic Determinants of Myocardial Infarction Risk in Familial Hypercholesterolemia
por: Zhao, Pei Jun, et al.
Publicado: (2019)

Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up
por: Auckle, Ranshaka, et al.
Publicado: (2017)

Identification of monocyte-associated genes as predictive biomarkers of heart failure after acute myocardial infarction
por: Chen, Qixin, et al.
Publicado: (2021)

Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia
por: Brænne, Ingrid, et al.
Publicado: (2014)

Premature Valvular Heart Disease in Homozygous Familial Hypercholesterolemia
por: Fahed, Akl C., et al.
Publicado: (2017)

Atheroprotective effects of statins in patients with unstable angina by regulating the blood-borne microRNA network
por: Li, Sufang, et al.
Publicado: (2017)

COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
por: Myers, Kelly D., et al.
Publicado: (2021)

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Decreased miR-92a-3p expression potentially mediates the pro-angiogenic effects of oxidative stress-activated endothelial cell-derived exosomes by targeting tissue factor
por: Li, Sufang, et al.
Publicado: (2020)

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Effects of statin on circulating microRNAome and predicted function regulatory network in patients with unstable angina
por: Li, Jingjin, et al.
Publicado: (2015)

High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease
por: Pirazzi, Carlo, et al.
Publicado: (2019)

Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia
por: Ravnskov, Uffe, et al.
Publicado: (2022)

Premature morbidity and mortality associated with potentially undiagnosed familial hypercholesterolemia in the general population
por: Ray, Kausik K., et al.
Publicado: (2023)

Applications of machine learning in familial hypercholesterolemia
por: Luo, Ren-Fei, et al.
Publicado: (2023)

Renal and Splenic Infarction in a Patient with Familial Hypercholesterolemia and Previous Cerebral Infarction
por: el Barzouhi, Abdelilah, et al.
Publicado: (2018)

Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report: Anticardiolipin antibody and myocardial infarction
por: Su, Xin, et al.
Publicado: (2019)

Acute myocardial infarction in an 18 year old South Indian girl with familial hypercholesterolemia: a case report
por: Kumar, Anita A, et al.
Publicado: (2008)

Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
por: Kovanen, Petri T., et al.
Publicado: (2021)

Familial Hypercholesterolemia in Premature Acute Coronary Syndrome. Insights from CholeSTEMI Registry
por: Lorca, Rebeca, et al.
Publicado: (2020)

Prevalence of familial hypercholesterolemia in patients with confirmed premature coronary artery disease in Ranchi, Jharkhand
por: Kumar, Prakash, et al.
Publicado: (2022)

Role of an automated screening tool for familial hypercholesterolemia in patients with premature coronary artery disease
por: Jokiniitty, Antti, et al.
Publicado: (2022)

Premature Myocardial Infarction: A Community Study
por: Dugani, Sagar B., et al.
Publicado: (2021)

Premature Myocardial Infarction: A Rising Threat
por: Kayikcioglu, Meral, et al.
Publicado: (2022)

Coronary lesion complexity in patients with heterozygous familial hypercholesterolemia hospitalized for acute myocardial infarction: data from the RICO survey
por: Yao, Hermann, et al.
Publicado: (2021)

Prevalence of genetically defined familial hypercholesterolemia and the impact on acute myocardial infarction in Taiwanese population: A hospital-based study
por: Chen, Yen-Ju, et al.
Publicado: (2022)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction
por: Gao, Jing, et al.
Publicado: (2021)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
por: Du, Zhiyong, et al.
Publicado: (2023)

The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype–Phenotype Correlations of the Disease
por: Kamar, Amina, et al.
Publicado: (2021)

Women with familial hypercholesterolemia phenotype are undertreated and poorly controlled compared to men
por: Zamora, Alberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pokj1g96f11enh79m8cm02ojht